Results 161 to 170 of about 317,688 (249)

Otorhinolaryngologists and Coronavirus Disease 2019 (COVID-19)

International Archives of Otorhinolaryngology, 2020
Geraldo Pereira Jotz, Richard Louis Voegels, Ricardo Ferreira Bento   +2 more
doaj   +1 more source

Seasonal Variations of Vogt-Koyanagi-Harada Disease in Japan: A Study on Long-Term Trends and the Influence of Coronavirus Disease 2019 (COVID-19). [PDF]

Ophthalmol Sci
Mizuki Y, Meguro A, Yamamoto K, Kawagoe T, Horita N, Okada H, Yamada N, Sakono T, Ishihara M, Ohno S, Mizuki N.   +10 more
europepmc   +1 more source

Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID‑19) pneumonia during the first chemotherapy cycle: A case report

, 2021
Ziping Li, Yan Chen, Bohan Yang, Haiping Song, Wanxin Chen, Hao Zhou   +5 more
openalex   +2 more sources

Developing New Drugs for the COVID‐19 Emergency: Anatomy of the U.S. Response

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
ABSTRACT Context To meet the need for effective treatments during the COVID‐19 Public Health Emergency, the U.S. government sought to accelerate the discovery and development of new antiviral treatments—a process that normally took 4–12 years.
Thomas J. Moore, Mariana P. Socal, Gerard Anderson   +2 more
wiley   +1 more source

The Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Postgraduate Training in Obstetrics and Gynaecology: A Global Perspective. [PDF]

Cureus
Schapira K, Govind A, Lakhi N.
europepmc   +1 more source

Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 583-595, March 2025.
ABSTRACT Prior pharmacokinetic (PK) analysis revealed that increased alpha‐1‐acid glycoprotein (AAG) levels are associated with decreased imatinib unbound fraction in coronavirus disease 2019 (COVID‐19) patients. This study aimed to investigate the PK of total and unbound concentrations of imatinib and the metabolite N‐desmethyl imatinib in ...
Medhat M. Said, Job R. Schippers, Leila Atmowihardjo, Yingxue Li, Mick S. van der Plas, Harm J. Bogaard, Lieuwe D. J. Bos, Ron A. A. Mathôt, Jurjan Aman, Eleonora L. Swart, Imke H. Bartelink   +10 more
wiley   +1 more source

Hospital Breastfeeding Support during the Early Coronavirus Disease 2019 (COVID-19) Pandemic: Worsening Care for Black, Hispanic, and Asian Mothers. [PDF]

Matern Child Health J
Lazar Tucker J, Arcoleo K, DiTomasso D, Oaks BM, Cabral H, São-João T.   +5 more
europepmc   +1 more source

Advancement of European Union Countries in Sustainable Development Goal 7

Sustainable Development, EarlyView.
ABSTRACT The United Nations 2030 Agenda identifies 17 Sustainable Development Goals, along with Goal 7 on ‘ensuring access to affordable, reliable, sustainable and modern energy for all’. Achieving it is a major challenge for countries, including the European Union member states.
Mariola Grzebyk, Barbara Fura, Małgorzata Stec, Alina Szewc‐Rogalska   +3 more
wiley   +1 more source

Successful Treatment of Post-coronavirus Disease 2019 (COVID-19) Autoimmune Encephalitis With Plasmapheresis After a Failed Trial of Steroids. [PDF]

Cureus
Kamel T, Toppen W, Salahmand Y.
europepmc   +1 more source

Novel Wide‐Spectrum Virucidal Lipid Nanoparticles

Small, EarlyView.
POSTAN is a novel broad‐spectrum antiviral nanoparticle that combines safety with potent virucidal activity. Composed of biocompatible lipids, it mimics heparan sulfate proteoglycans and lipid rafts exploited by viruses, thereby dismantling viral envelopes and blocking replication.
Yugo Araújo Martins, Louise Bondeelle, Arnaud Charles‐Antoine Zwygart, Thais Melquiades de Lima, Juliano de Paula Souza, Han Kang Tee, Fernando Chahud, Eurico de Arruda Neto, Francesco Stellacci, Renata Fonseca Vianna Lopez, Caroline Tapparel   +10 more
wiley   +1 more source